1. Home
  2. MSGM vs INTS Comparison

MSGM vs INTS Comparison

Compare MSGM & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Motorsport Games Inc.

MSGM

Motorsport Games Inc.

HOLD

Current Price

$4.30

Market Cap

13.4M

Sector

Technology

ML Signal

HOLD

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$3.92

Market Cap

12.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSGM
INTS
Founded
2018
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4M
12.4M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
MSGM
INTS
Price
$4.30
$3.92
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$38.00
AVG Volume (30 Days)
47.2K
23.8K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
252.13
N/A
EPS
0.06
N/A
Revenue
$741,000.00
N/A
Revenue This Year
$69.73
N/A
Revenue Next Year
$146.81
N/A
P/E Ratio
$72.67
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.11
$0.19
52 Week High
$5.78
$8.06

Technical Indicators

Market Signals
Indicator
MSGM
INTS
Relative Strength Index (RSI) 47.36 35.46
Support Level $3.95 $0.31
Resistance Level $4.57 $8.06
Average True Range (ATR) 0.22 0.23
MACD -0.01 -0.02
Stochastic Oscillator 63.64 36.83

Price Performance

Historical Comparison
MSGM
INTS

About MSGM Motorsport Games Inc.

Motorsport Games Inc is a motorsport network company that combines engaging video games with esports competitions and content for racing fans and gamers around the globe. The company has its reportable segments into the development and publishing of interactive racing video games, entertainment content and services, and the organization and facilitation of esports tournaments, competitions, and events for licensed racing games as well as on behalf of third-party video game racing series and other video game publishers. The majority of the revenue is earned from Gaming.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc . is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.

Share on Social Networks: